Is Methylergonovine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 1 valid registration of Methylergonovine, including METHERGINE 0.2MG-ML AMPULES (0.2 mg/ml, Solution for injection, SAR 10.15).

Is Methylergonovine approved by the US FDA?

Drugs@FDA lists 10 application product lines for Methylergonovine, including METHYLERGONOVINE MALEATE (Prescription); METHYLERGONOVINE MALEATE (Prescription); METHYLERGONOVINE MALEATE (Prescription); METHYLERGONOVINE MALEATE (Prescription); METHYLERGONOVINE MALEATE (Prescription).

Are there safety signals or safety updates for Methylergonovine?

US FDA: 1 entry (latest 2025-05-29).

Active substance

Methylergonovine

SFDA 2
US FDA 10
US price lines 1
Safety 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
METHERGINE 0.2MG-ML AMPULES	0.2 mg/ml	Solution for injection · Intravenous use	1 Ampoule	SAR 10.15	NCE · Prescription	Essential Pharma Switzerland GmbH	Valid
METHERGINE 0.125 mg tablet	0.125 mg	Tablet · Oral use	30 Blister	SAR 13.35	NCE · Prescription	NOVARTIS	Withdrawn by MAH · Not Marketed

Indications — CHI Daman Drug Formulary

ANESTHESIA-OBSTETRIC USE/ FACILITATING UTERINE CONTRACTION; MATERNAL AND CHILD HEALTHCARE- PERINATAL,INTRAPARTUM AND POSTPARTUM CARE

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
METHYLERGONOVINE MALEATE	0.2MG/ML	injectable · injection	AM REGENT	Prescription	24 Nov 2008
METHYLERGONOVINE MALEATE	0.2MG/ML	injectable · injection	BRECKENRIDGE	Prescription	13 Sep 2010
METHYLERGONOVINE MALEATE	0.2MG	tablet · oral	CHARTWELL RX	Prescription	2 May 2011
METHYLERGONOVINE MALEATE	0.2MG	tablet · oral	GRANULES	Prescription	15 May 2018
METHYLERGONOVINE MALEATE	0.2MG	tablet · oral	AMNEAL PHARMS	Prescription	10 Sep 2018
METHYLERGONOVINE MALEATE	0.2MG	tablet · oral	TEVA PHARMS USA	Prescription	20 Mar 2019
METHYLERGONOVINE MALEATE	0.2MG	tablet · oral	TP ANDA HOLDINGS	Prescription	1 May 2020
METHYLERGONOVINE MALEATE	0.2MG	tablet · oral	RISING	Prescription	15 Jan 2021
METHERGINE	0.2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	tablet · oral	EDISON THERAPS LLC	Discontinued	19 Nov 1946
METHERGINE	0.2MG/ML	injectable · injection	EDISON THERAPS LLC	Discontinued	19 Nov 1946

Prices — United States and England

Source	Product as listed	Price	Unit / pack	Date
US NADAC	METHYLERGONOVINE 0.2 MG TABLET	$4.49722	per EA	23 Sep 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Safety signals and safety-related labeling changes

US FDA 29 May 2025 METHERGINE — safety-related labeling change
Labeling sections changed: Warnings and Precautions

All safety entries for methylergonovine →

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.